# Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis

> **NCT01580865** · NA · COMPLETED · sponsor: **Ramathibodi Hospital** · enrollment: 84 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis

## Key facts

- **NCT ID:** NCT01580865
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2018-09-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580865, "Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01580865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*